Strasbourg (France), March 11, 2025, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today ...
Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this ...
AskBio has dosed the first participant in the second group of a Phase 1/2 trial of AB-1003, an experimental gene therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback